Paeds Vivas · infectious-diseases
Enteric fever and invasive bacterial enteritis — branching viva
Structured oral on the stepwise fever of enteric fever, blood-versus-stool diagnostics, XDR-aware treatment, the STEC-HUS danger, and vaccine prevention.
On this page & tools
Target exams
Opening (2-3 minutes)
Examiner: Two children with fever and abnormal stools. Walk me through how you separate them. [1]
Strong answer: I separate invasive from non-invasive disease. The 9-year-old has a stepwise fever with relative bradycardia, constipation and abdominal pain after travel to Pakistan — that is enteric fever until proven otherwise, and I draw blood culture before antibiotics. The 4-year-old has bloody diarrhoea with little fever after a farm visit — that is Shiga-toxin producing E. coli colitis until I prove otherwise, and I send stool, watch for haemolytic uraemic syndrome, and avoid routine antibiotics. [1] [12]
Branch A — Diagnosing enteric fever
Examiner: What is your diagnostic strategy for the 9-year-old? [1]
Strong answer: Blood culture is the gold standard and I take it before any antibiotic, repeating if negative and suspicion persists. If he has already had antibiotics, bone marrow culture has the highest yield. I send stool and urine cultures and a malaria film to exclude the key mimic. I do not rely on a single Widal test — it is insensitive and non-specific, and a negative or positive result does not decide management. [1]
Branch B — XDR and antibiotic choice
Examiner: He is from Pakistan. What does that mean for your antibiotic? [8]
Strong answer: Travel to Pakistan raises the probability of extensively drug-resistant typhoid — resistant to fluoroquinolones and third-generation cephalosporins. I start oral azithromycin empirically for uncomplicated disease, with meropenem reserved for severe, complicated or refractory XDR. For non-XDR fluoroquinolone-resistant strains, azithromycin or ceftriaxone is reasonable. I narrow once susceptibilities return and treat for seven to fourteen days. [8] [4]
Branch C — Complications
Examiner: In week three he develops sudden severe abdominal pain and a rigid abdomen. What is happening? [1]
Strong answer: Intestinal perforation through an ulcerated Peyer's patch, with secondary peritonitis — a surgical emergency in weeks three to four of typhoid. I keep him nil by mouth, gain intravenous access, give fluid resuscitation and broad-spectrum antibiotics covering gut flora, and obtain urgent surgical review and imaging. I do not attribute new symptoms to the original gastroenteritis label. [1]
Branch D — The STEC-HUS danger
Examiner: Back to the 4-year-old. Five days on she is pale with petechiae and oliguria. Reason with me. [12]
Strong answer: Evolving haemolytic uraemic syndrome from STEC. I check a full blood count and film (microangiopathic haemolytic anaemia with schistocytes), platelets (thrombocytopenia), creatinine and electrolytes (acute kidney injury) and LDH. I avoid routine antibiotics and nephrotoxins, give careful intravenous fluids to protect renal perfusion, and refer early to nephrology for supportive care and dialysis if needed. [12]
Branch E — Prevention
Examiner: How do you prevent the next case? [5]
Strong answer: The typhoid conjugate vaccine — Vi-tetanus toxoid conjugate — is the prevention cornerstone, shown to have roughly eighty-seven per cent efficacy in the controlled human infection model (Jin 2017) and confirmed in field trials. The WHO recommends routine use in endemic countries and I advise it for travellers. Safe water, sanitation, hand hygiene and food safety are the structural foundation. Enteric fever and shigellosis are notifiable, so I notify public health and trace contacts. [5]
Examiner scoring cues
Pass: invasive-versus-non-invasive framing; blood culture before antibiotics; bone marrow if pre-treated; XDR-aware empiric choice; recognition of perforation and HUS; no routine antibiotics in STEC; vaccine and notification. [1] [4] [12] Fail: empiric antibiotics before culture; reliance on Widal; missed XDR; routine antibiotics in STEC; rigid abdomen attributed to "gastro"; no vaccine or public-health plan. [8] [13]
References
- [1]Wain J, Hendriksen RS, Mikoleit ML, Keddy KH, Ochiai RL, Typhi G Typhoid fever Lancet (London, England), 2015.PMID 25458731
- [4]Parry CM, Qamar FN, Rijal S, McCann N What should we be recommending for the treatment of enteric fever? Open Forum Infectious Diseases, 2023.PMID 37274536
- [5]Jin C, Gibani MM, Moore M, Juel HB, Pollard AJ Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial Lancet (London, England), 2017.PMID 28965718
- [8]Carey ME, Dyson ZA, Ingle DJ, Amir A, Baker S, Holt KE Global diversity and antimicrobial resistance of typhoid fever pathogens: insights from a meta-analysis of 13,000 Salmonella Typhi genomes eLife, 2023.PMID 37697804
- [12]Nataro JP, Kaper JB Diarrheagenic Escherichia coli Clinical Microbiology Reviews, 1998.PMID 9457432
- [13]Christopher PR, David KV, John SM, Sankarapandian V Antibiotic therapy for Shigella dysentery Cochrane Database of Systematic Reviews, 2010.PMID 20687081